Department of Pathology, University of Michigan Hospitals, Ann Arbor, Michigan, USA.
St. Joseph Trinity Hospital, Ann Arbor, Michigan, USA.
J Clin Apher. 2023 Aug;38(4):427-436. doi: 10.1002/jca.22046. Epub 2023 Mar 14.
Ethylene oxide (EtO) is a volatile, ringed toxic ether used to sterilize heat-labile plastics including apheresis sets. In the 1980s, EtO-associated severe hypersensitivity reactions during hemodialysis led to widespread adoption of alternative sterilization for dialysis kits but not apheresis tubing sets. We now report several cases of EtO-type hypersensitivity reactions in autologous donors undergoing hematopoietic progenitor cell collection (HPCC).
A 10-year retrospective review of allergic EtO-type reactions in adults undergoing HPCC on the COBE Spectra and SPECTRA Optia was performed. Donor medical history and absolute eosinophil counts were compared between cases and 34 HPCC controls. Published EtO reactions during extracorporeal procedures were reviewed with statistical analysis. Graphics and statistics were performed using commercial software.
Three autologous HPCC donors experienced EtO-type reactions within 15 min of initiating HPCC, for a 10-year incident rate of 0.08% per procedure and 0.18% per donor. All three reactions occurred using the Spectra Optia and IDL tubing set, for an Optia/IDL specific rate of 0.2% per procedure and 0.5% per donor. There was no correlation between EtO reactions, eosinophil counts, or saline prime dwell times. No patient had classic predisposing risk factors for EtO hypersensitivity. Two patients required medical intervention whereas the third responded by pausing the procedure and slowing the inlet rate.
EtO-type hypersensitivity reactions can be observed during HPCC, especially with the Optia IDL tubing set. EtO reactions may be missed due to their rarity and staff unfamiliarity with this clinical entity.
环氧乙烷(EtO)是一种挥发性、环状有毒醚,用于对包括单采套件在内的不耐热塑料进行灭菌。20 世纪 80 年代,在血液透析过程中 EtO 相关性严重超敏反应导致广泛采用替代方法对透析套件进行灭菌,但单采套件仍采用 EtO 灭菌。我们现在报告几例在接受造血祖细胞采集(HPCC)的自体供者中发生的 EtO 型超敏反应。
对在 COBE Spectra 和 SPECTRA Optia 上接受 HPCC 的成人进行了为期 10 年的回顾性过敏 EtO 型反应病例研究。对病例和 34 例 HPCC 对照者的供者病史和绝对嗜酸性粒细胞计数进行了比较。对体外程序中的已发表 EtO 反应进行了回顾性分析,并进行了统计学分析。图形和统计分析使用商业软件进行。
3 例自体 HPCC 供者在启动 HPCC 后 15 分钟内发生 EtO 型反应,每例的发生率为 0.08%,每例供者的发生率为 0.18%。所有 3 例反应均发生在使用 Spectra Optia 和 IDL 管套件时,Optia/IDL 特定的发生率为每例 0.2%,每例供者 0.5%。EtO 反应、嗜酸性粒细胞计数或生理盐水预充停留时间之间无相关性。无患者具有 EtO 超敏反应的经典易患危险因素。2 例患者需要医疗干预,而第 3 例患者通过暂停手术和减慢入口速度来应对。
EtO 型超敏反应可在 HPCC 过程中观察到,尤其是在使用 Optia IDL 管套件时。由于其罕见性和工作人员对该临床实体的不熟悉,EtO 反应可能会被遗漏。